Blue Sky Peptide Intelligence Profile
Research Incomplete
Research coverage for this vendor is 74%. Our research on Blue Sky Peptide remains incomplete — what we have verified so far is published below, and research is continuing.
Still to research:
- Research coverage ≥ 80%
- Legal entity researched (legal_entity_name)
- Registration jurisdiction researched (state_of_registration)
- Entity status researched (entity_status)
- Payment methods reviewed (accepted_payment_methods)
- Public summary reviewed
Overview#
Blue Sky Peptide is a long-running U.S. research-peptide storefront (operating since 2013 per the vendor; domain created 2013-06-08) selling peptides and research liquids for laboratory use, U.S. shipping only. Its transparency profile is split: commercial and testing disclosure is comparatively strong — published shipping rates and a 30-day return policy, plus a public per-product COA library — while corporate disclosure is effectively zero: no legal entity, principal, registered agent, or address is published anywhere found (Florida Sunbiz name search found no matching entity), and independent graders treat its ownership as anonymous. All defined regulatory searches (FDA warning letters, recalls, import alerts, FTC, state AG, civil litigation including the 2026 Lilly retatrutide suits, criminal/injunctive) returned No Record Found in the defined search. Testing evidence names MZ Biolabs (Tucson, AZ) on the single independently indexed record (BPC-157 Lot 1SWB0126, 99.79%, 2026-06-23); the vendor's catalog-wide every-batch claim is not independently confirmed beyond that record, and no public COA verification portal exists. Payment methods are not published. The identity block is the material gap. No serious findings.
Company Identity#
Domain and Digital Identity#
Regulatory and Legal History#
Testing and COA Evidence#
Payment, Refund and Shipping#
Material Changes#
No material changes recorded.